Intravenous lidocaine administration is gaining interest as adjuvant in post-operative pain control. Its use has been proven to be safe and effective in abdominal, breast, spinal surgery, and, more recently, also in thoracic surgery. Lidocaine aids reducing opioid consumption, that could contribute to post-operative pulmonary complications and may be implicated in cancer recurrence.
We conducted a pilot case-control study to investigate if such findings would be confirmed in our clinical practice.
Key words: intravenous lidocaine, post-operative pain, opioid consumption